Kathryn L. Zephir

Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

Mario Roederer, Barney S. Graham, Sumana Chakravarty, 2013, Science.

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Mario Roederer, Sumana Chakravarty, Martha C Nason, 2016, Nature Medicine.

Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

Mario Roederer, Sumana Chakravarty, Martha C Nason, 2017, Proceedings of the National Academy of Sciences.

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

J. Mascola, T. Pierson, C. Andrews, 2017, The Lancet.

Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect.

J. Mascola, R. Koup, G. Nabel, 2013, The Journal of infectious diseases.

Correction: Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Andrea A. Berry, S. Hoffman, S. Kappe, 2016, Nature Medicine.

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

U. Baxa, J. Mascola, R. Koup, 2018, Nature Immunology.

An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

J. Mascola, R. Koup, R. Bailer, 2017, npj Vaccines.

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

U. Baxa, J. Mascola, R. Koup, 2018, Nature Immunology.